22-ICRAD Call 2 - Q-Net-Assess (Improved molecular surveillance and assessment of host adaptation and virulence of Coxiella burnetii in Europe)
Lead Research Organisation:
MOREDUN RESEARCH INSTITUTE
Department Name: Disease Control
Abstract
Q fever is an important zoonotic pathogen caused by the bacterium Coxiella burnetii. Clinical signs in humans range from more common flu-like symptoms to persistent and potentially fatal infections. Ruminant livestock, and sheep and goats in particular, are the primary source of human infections, although C. burnetii can infect a wide range of other animals including wildlife and ticks. In ruminants, C. burnetii can cause abortion, stillbirth and weak offspring, particularly in sheep and goats, although most infections are asymptomatic. Thus, host range and outcome of infection is highly variable. However, our understanding of how C. burnetii genotype contributes to this variation is limited.
The main genotyping methods currently used for C. burnetii generate only limited genomic information and are difficult to standardise between laboratories. Whole genome sequencing (WGS) has revolutionised molecular epidemiology and surveillance of many zoonotic pathogens as it provides comprehensive genetic information and is easily standardised. However, few C. burnetii strains are currently available for WGS, largely due to difficulties in isolating the bacteria from field samples.
We have assembled a consortium with unique expertise in C. burnetii surveillance and genomics to allow collation of C. burnetii positive samples from a wide range of hosts (livestock, wildlife and humans) with accurate clinical data. C. burnetii will be isolated from these samples using optimised isolation methods. Isolated strains, plus available archived strains, will be submitted for WGS to generate a comprehensive database of annotated C. burnetii genomes, which will include phenotypic data from the field and in-vitro cellular assays. WGS data will be analysed using novel bioinformatics approaches to identify molecular determinants of C. burnetii host range and virulence. Finally, project outputs will be synthesised into a recommended framework for future molecular surveillance of C. burnetii.
The main genotyping methods currently used for C. burnetii generate only limited genomic information and are difficult to standardise between laboratories. Whole genome sequencing (WGS) has revolutionised molecular epidemiology and surveillance of many zoonotic pathogens as it provides comprehensive genetic information and is easily standardised. However, few C. burnetii strains are currently available for WGS, largely due to difficulties in isolating the bacteria from field samples.
We have assembled a consortium with unique expertise in C. burnetii surveillance and genomics to allow collation of C. burnetii positive samples from a wide range of hosts (livestock, wildlife and humans) with accurate clinical data. C. burnetii will be isolated from these samples using optimised isolation methods. Isolated strains, plus available archived strains, will be submitted for WGS to generate a comprehensive database of annotated C. burnetii genomes, which will include phenotypic data from the field and in-vitro cellular assays. WGS data will be analysed using novel bioinformatics approaches to identify molecular determinants of C. burnetii host range and virulence. Finally, project outputs will be synthesised into a recommended framework for future molecular surveillance of C. burnetii.
Technical Summary
The Q-Net-Assess project will take a functional genomics approach to understand C. burnetii host adaptation and virulence. Combined analysis of Whole genome Sequencing data from C. burnetii strains from different hosts (domestic ruminants, humans, wildlife), of in vitro phenotypes and of geo-referenced meta-data will reveal molecular determinants that control C. burnetii host adaptation and link genetic traits to differences in zoonotic potential and clinical relevance. This information can be used to determine upcoming zoonotic threats posed by C. burnetii, and provide a framework for assessing the risk and severity of future Q fever outbreaks.
The major difficulty in C. burnetii genomics is the lack of sequenced strains and associated meta-data. We have assembled a consortium with unique expertise in C. burnetii surveillance and genomics, and with direct or indirect links to six European national Q fever Reference Laboratories. This has allowed the collation of >100 C. burnetii isolates for genome sequencing, and a biobank of >350 samples with high C. burnetii loads for bacterial isolation. This will be supplemented by prospective sampling from each participating country. In addition, this project will optimise C. burnetii isolation methodologies, and explore long-read sequencing to directly sequence from clinical samples and to assemble fully annotated genomes.
Key to genome association studies is accurate phenotypic data, which will be obtained from surveillance laboratories and through use of cutting-edge in vitro assays. Novel bioinformatic and artificial intelligence approaches will be used to identify molecular determinants of C. burnetii host range and virulence, which may be targeted using specific molecular probles to rapidly determine host/virulence potential. Finally, we will synthesise project outputs into a recommended Pan-European framework for molecular surveillance of C. burnetii.
The major difficulty in C. burnetii genomics is the lack of sequenced strains and associated meta-data. We have assembled a consortium with unique expertise in C. burnetii surveillance and genomics, and with direct or indirect links to six European national Q fever Reference Laboratories. This has allowed the collation of >100 C. burnetii isolates for genome sequencing, and a biobank of >350 samples with high C. burnetii loads for bacterial isolation. This will be supplemented by prospective sampling from each participating country. In addition, this project will optimise C. burnetii isolation methodologies, and explore long-read sequencing to directly sequence from clinical samples and to assemble fully annotated genomes.
Key to genome association studies is accurate phenotypic data, which will be obtained from surveillance laboratories and through use of cutting-edge in vitro assays. Novel bioinformatic and artificial intelligence approaches will be used to identify molecular determinants of C. burnetii host range and virulence, which may be targeted using specific molecular probles to rapidly determine host/virulence potential. Finally, we will synthesise project outputs into a recommended Pan-European framework for molecular surveillance of C. burnetii.
Organisations
- MOREDUN RESEARCH INSTITUTE (Lead Research Organisation)
- Aix-Marseille University (Collaboration)
- Experimental Zooprophylactic Institute of the Venezie (Collaboration)
- Ceva Sante Animale (Collaboration)
- Institute of Tropical Medicine Antwerp (Collaboration)
- Center for Biomedical Research of La Rioja (Collaboration)
- Austrian Agency for Health and Food Safety (Collaboration)
Publications
McNeilly TN
(2025)
Q Fever (Coxiellosis) Factsheet
McNeilly TN
(2024)
Rational design of an effective ruminant sub-unit Q fever vaccine
| Description | PhD studentship: Exploration of risk posed by ruminant associated Coxiella burnetii to GB livestock and human health |
| Amount | £1,034,492 (GBP) |
| Organisation | Animal and Plant Health Agency |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2023 |
| End | 08/2026 |
| Title | Direct sequencing of Coxiella burnetii from PCR positive samples |
| Description | This method uses elective Whole Genome Amplification (SWGA) of Coxiella burnetii and subsequent long read sequencing using Oxford Nanopore technologies to obtain full genome sequences from clinical samples positive for C. burnetii by PCR. This allows genomic information to be obtained from samples from which C. burnetii is unculturable and has the potential to revolutionise C. burnetii genomics. |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2025 |
| Provided To Others? | Yes |
| Impact | This protocol is currently ondergoing ring-trial assessment by consortium partners including 'hop-on' partners from Human Q fever surveillance laboratories. |
| Title | Q fever clinical database |
| Description | A database has been created to include all cases of Q fever in ruminants from 8 european countries - UK, France, Germany, Netherlands, Belgium, Spain, Italy and Austria which have associated clinical data and samples for isolation. The database includes information on the species affected, region, clinical presentation, and samples collected. |
| Type Of Material | Database/Collection of data |
| Year Produced | 2023 |
| Provided To Others? | No |
| Impact | The database allows selection of samples for isolation of Coxiella burnetii. Any isolated strains will be subjected to whole genome sequencing to identify genetic elements associated with host range and pathogenicity. The database will be made publicly available and act as a resource for others to conduct future research. |
| Description | Genetic diversity of Coxiella burnetii in Austrian livestock |
| Organisation | Austrian Agency for Health and Food Safety |
| Country | Austria |
| Sector | Public |
| PI Contribution | We provide expertise in bacterial genomics. We will perform whole genome sequencing of Coxiella burnetii from samples provided by the partner, and perform pangenomic analyses to identify genetic determinants of host range and pathogenicity for C. burnetii. |
| Collaborator Contribution | The partners have provided samples from clinical cases of Q fever in livestock which have high Coxiella burnetii load. these samples are currently being used to isolate strains of C. burnetii originating from Austrian livestock. |
| Impact | Outputs will include the generation of whole genome sequencing data of Coxiella burnetii from Austrian livestock which will be used for pangenomic analysis to identify genetic determinants of host range and pathogenicity for Coxiella burnetii. The collaboration will also allow standardisation of molecular surveillance of Coxiella burnettii across Europe. |
| Start Year | 2023 |
| Description | Genetic diversity of Coxiella burnetii in Italian livestock |
| Organisation | Experimental Zooprophylactic Institute of the Venezie |
| Country | Italy |
| Sector | Public |
| PI Contribution | We provide expertise in bacterial genomics. We will perform whole genome sequencing of Coxiella burnetii from samples provided by the partner, and perform pangenomic analyses to identify genetic determinants of host range and pathogenicity for C. burnetii. |
| Collaborator Contribution | The partners have provided samples from clinical cases of Q fever in livestock which have high Coxiella burnetii load. these samples are currently being used to isolate strains of C. burnetii originating from italian livestock. |
| Impact | Outputs will include the generation of whole genome sequencing data of Coxiella burnetii from Italian livestock which will be used for pangenomic analysis to identify genetic determinants of host range and pathogenicity for Coxiella burnetii. The collaboration will also allow standardisation of molecular surveillance of Coxiella burnettii across Europe. |
| Start Year | 2023 |
| Description | Genetic diversity of Coxiella burnetii in human clinical cases - Belgium |
| Organisation | Institute of Tropical Medicine Antwerp |
| Country | Belgium |
| Sector | Academic/University |
| PI Contribution | We provide expertise in bacterial genomics. We will perform whole genome sequencing of Coxiella burnetii from human clinical samples provided by the partner, and perform pangenomic analyses to identify genetic determinants of host range and pathogenicity for C. burnetii. |
| Collaborator Contribution | The partners have provided samples from clinical cases of Q fever in humans which have high Coxiella burnetii load for bacterial isolation. The partner will also provide C. burnetii strains previously isolated from human cases for sequencing. |
| Impact | The project partner has contributed to project meetings. |
| Start Year | 2025 |
| Description | Genetic diversity of Coxiella burnetii in human clinical cases - France |
| Organisation | Aix-Marseille University |
| Country | France |
| Sector | Academic/University |
| PI Contribution | We provide expertise in bacterial genomics. We will perform whole genome sequencing of Coxiella burnetii from human clinical samples provided by the partner, and perform pangenomic analyses to identify genetic determinants of host range and pathogenicity for C. burnetii. |
| Collaborator Contribution | The partners have provided samples from clinical cases of Q fever in humans which have high Coxiella burnetii load for bacterial isolation. The partner will also provide C. burnetii strains previously isolated from human cases for sequencing. |
| Impact | This is a multi-disciplinary collaboration involving human and veterinary surveillance teams. To date, the partner has contributed whole genome sequence information for analysis and has contributed to a review of human Q fever surveillance produced by the consortium. |
| Start Year | 2025 |
| Description | Genetic diversity of Coxiella burnetii in human clinical cases - Spain |
| Organisation | Center for Biomedical Research of La Rioja |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | We provide expertise in bacterial genomics. We will perform whole genome sequencing of Coxiella burnetii from human clinical samples provided by the partner, and perform pangenomic analyses to identify genetic determinants of host range and pathogenicity for C. burnetii. |
| Collaborator Contribution | The partners have provided samples from clinical cases of Q fever in humans which have high Coxiella burnetii load for bacterial isolation. |
| Impact | The partner has participated in project meetings |
| Start Year | 2025 |
| Description | Molecular epidemiology of Coxiella burnetii in Europe using the Q-test technology |
| Organisation | Ceva Sante Animale |
| Country | France |
| Sector | Private |
| PI Contribution | We provide expertise in bacterial genomics. We will perform sequence typing of Coxiella burnetii from DNA extracted from Q-test cards which have been collected from bulk milk tanks of dairy ruminants throughought Europe. |
| Collaborator Contribution | The partner will supply Q-test cards positive for Coxiella burnetii DNA. |
| Impact | Outputs will include the generation of sequence typing data of Coxiella burnetii from European livestock which will be used to identify genetic determinants of host range and pathogenicity for Coxiella burnetii. |
| Start Year | 2023 |
| Description | 6th European Meeting of Animal Chlamydioses & Zoonoses (EMAC-6): Presentation on Q fever vaccines development and genetic diversity of Coxiella burnetii. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | A talk was given on the development of subunit Q fever vaccines and how these can be integrated into molecular surveillance programmes for Q fever. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.um.es/esacz/meetings.html |
| Description | Human-veterinary Q fever workshop |
| Form Of Engagement Activity | Participation in an activity, workshop or similar |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | A workshop was held with the aim of linking human surveillance and reference laboratories with the European veterinary Q fever reference laboratories participating in the Q-Net Assess project. This was attended by 29 staff from Human reference laboratories from the UK, Germany, France, Spain, Austria, Belgium and the Netherlands and resulted in agreement to collaborate with the Q-Net-Assess consortium to provide Coxiella burnetii strains, genome sequence information, and C. burnetii positive samples from human Q fever cases. It also resulted in human reference laboratories joining the consortium as 'hop'on' partners. |
| Year(s) Of Engagement Activity | 2024 |
| Description | Poster presentation at 2024 Symposium on Diagnostic and surveillance of infectious diseases on Q-Net-Assess |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Professional Practitioners |
| Results and Impact | A poster presentation was given at the 2024 Symposium on Diagnostic and surveillance of infectious diseases entitled: Improved molecular surveillance and assessment of host adaptation and virulence of Coxiella burnetii in Europe. Fluyt L, Matthijs A, Mori, M. This provided an overview of the project and was aimed at any healthcare provider with an interest in infectious diseases: microbiologists, infectious disease specialists, hygienists, laboratory technicians, epidemiologists, public health personnel. The poster presentation led to discussions about the project and fostered collaboration with human surveillance teams. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.sciensano.be/en/events/2024-symposium-diagnostic-and-surveillance-infectious-diseases |
| Description | Poster presentation at International One Health Symposium Berlin 2024 on Q-Net-Assess project |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | A poster presentation was given at the International One Health Symposium Berlin in October 2024. The poster led to further discussions about the project and potential future collaboration. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://zoonosen.net/international-one-health-symposium-berlin |
| Description | Poster presentation at the 12th Annual Edinburgh Infectious Diseases Symposium |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | National |
| Primary Audience | Postgraduate students |
| Results and Impact | A poster was presented on genetic diversity of Coxiella burnetii and how this information is being used to develop next generation Q fever vaccines. |
| Year(s) Of Engagement Activity | 2023 |
| URL | https://www.ed.ac.uk/edinburgh-infectious-diseases/news/news/12th-annual-symposium |
| Description | Presentation at The World Buiatrics Congress 2024: Rational design of an effective ruminant sub-unit Q fever vaccine |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Professional Practitioners |
| Results and Impact | A presentation was given on development of subunit vaccines to control Coxiellosis in ruminants. This included an overview of antigen selection and vaccine formulation and testing, which incorporated genomic analysis of Coxiella burnetii to determine cross-protection potential across different C. burnetii genomic groups. The audience was primarily veterinary practitioners but also included undergraduate and postgraduate students, and industry representatives. The presentation resulted in requests for further information, and discussion on coxiella genomics with a commerical partner. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://www.ivis.org/library/wab |
| Description | Q-Net-Assess website |
| Form Of Engagement Activity | Engagement focused website, blog or social media channel |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Public/other audiences |
| Results and Impact | A project website was created and launched in 2024. The website describes the project aims and objectives, provides updates on project progress and provides links to protocols and data arrising from the project. |
| Year(s) Of Engagement Activity | 2024 |
| URL | https://q-net-assess.com/ |
| Description | Seminar presentation at the Friedrich Loeffler Institute, Jena, Germany, on Q fever vaccine development and genetic diversity of Coxiella burnetii. |
| Form Of Engagement Activity | A talk or presentation |
| Part Of Official Scheme? | No |
| Geographic Reach | International |
| Primary Audience | Postgraduate students |
| Results and Impact | A seminar was given on the development of subunit vaccines to control Coxiella burnetii infections in livestock using reverse vaccination approaches, and how the understanding the genetic diversity of C. burnetii is critical for this work. |
| Year(s) Of Engagement Activity | 2023 |
